Clinical Trial Update: Real-world Immuno-therapy in Chinese Newly Diagnosed Multiple Myeloma Patients

View source ↗

Summary

Real-world immunotherapy trial for Chinese patients with newly diagnosed multiple myeloma is currently recruiting. Sponsor is Peking University People's Hospita…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Peking University People's Hospital | Conditions: Newly Diagnosed Multiple Myeloma (NDMM) | Status: RECRUITING